Background: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), also known as
NIH Category III Prostatitis is a highly prevalent syndrome with significant impact on quality …

The nonhormonal medical treatment can be divided into empirical, when the cause has not
been identified, and nonempirical, if the pathogenic mechanism causing male infertility can …

Objectives To improve awareness and recognition of chronic bacterial prostatitis (CBP) and
chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) among non‐specialists and …

Premature ejaculation (PE) is the most prevalent male sexual dysfunction, and the most
recently defined. PE is often mistakenly considered a purely psychosexological symptom by …

Prostatitis is a common urinary tract condition but bring innumerable trouble to clinicians in
treatment, as well as great financial burden to patients and the society. Bacterial prostatitis …

Ciprofloxacin (CP) has a confirmed cytotoxic action on some cancerous cells, but in high,
non-pharmacological concentrations. Considering features of natural fatty acids, such as …

Abstract Purpose of Review We conducted a review of the literature describing the most up-
to-date diagnosis and treatment options of chronic bacterial prostatitis. Recent Findings …

The complex network of etiological factors, signals and tissue responses involved in chronic
prostatitis/chronic pelvic pain syndrome (CP/CPPS) cannot be successfully targeted by a …

Abstract Purpose of Review Pathologies of the prostate in men are one of the most prevalent
clinical conditions today. Specifically, pelvic inflammatory disease such as prostatitis can …

Biofilm formation is becoming a predominant feature in nosocomial infections. Since biofilms
are increasingly resistant to antibiotics, making monotherapy ineffective, combination …